A Study of Brain Receptor Occupancy in Healthy Subjects
NCT01232439
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Alcohol Dependence
Interventions
DRUG:
opioid receptor kappa antagonist
Sponsor
Eli Lilly and Company